Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Not a discussion board

My take on this topic, is that it would be wise for J3/ARM to have been accumulating. That way, they would be "hedging" there risks no matter the outcome. With several million dollars they could have purchased a substantial number of millions of shares. In which case, if they lose, should eventually reduce their losses when the PTSC sp increases. If they win, the amount of money that they risked on the hedge would have been far than what they could have lost. Thanks,

T.K.

Share
New Message
Please login to post a reply